Johnson & Johnson Infants’ Tylenol Class Action Settlement

UPDATE: Top Class Actions viewers started receiving payments of $5.20 from the Johnson & Johnson Infants’ Tylenol class action settlement in late January 2021. Congratulations to everyone who filed a claim and got PAID!

Johnson & Johnson has agreed to pay up to $6.3 million to resolve claims that its Infants’ Tylenol was deceptively packaged as being uniquely formulated for babies.

The settlement will benefit consumers who purchased Johnson & Johnson Infants’ Tylenol between Oct. 3, 2014 and Jan. 6, 2020.

The Infants’ Tylenol class action lawsuit claimed that the pain reliever was marketed to new parents by including text references to “infants” along with a picture of a mother holding her child. These representations allegedly caused consumers to believe that the medicine was specially created for infants.

However, the plaintiffs say these representations were false. In fact, Infants’ Tylenol allegedly contained liquid acetaminophen that was the same concentration found in Children’s Tylenol. The misrepresentations reportedly caused consumers to overpay for the medication based on their belief that the pain reliever was special or unique.

Johnson & Johnson, the manufacturer of Tylenol, has denied any wrongdoing. According to the company, Infants’ Tylenol is associated with safety features for infants such as a syringe for safe dosing practices. However, the company has agreed to pay into a $6.315 million settlement to resolve the claims against them.

The Infants’ Tylenol class action settlement will provide $2.15 to consumer for every 1 or 2 fl. oz. bottles purchased. If a Class Member can provide proof of purchase (receipts, etc.), they can collect an unlimited number of bottles. If a Class Member does not provide proof of purchase, they can collect up to seven bottles for a maximum payment of $15.05.

In order to benefit from the Infants’ Tylenol class action settlement, Class Members need to file a valid Claim Form by April 13, 2020. The deadline for exclusion and objection is also April 13, 2020. The final approval hearing for the settlement is scheduled for May 11, 2020.

Who’s Eligible

Class Members include all U.S. residents who bought Johnson & Johnson Infants’ Tylenol between Oct. 3, 2014 and Jan. 6, 2020.

Potential Award

$2.15 per bottle.

Class Members can file a claim for up to seven bottles of Infants’ Tylenol without proof of purchase for a total of $15.05. Those consumers who can provide receipts may claim an unlimited number of bottles.

Proof of Purchase

Not required, but those Class Members who can provide a receipt or other documentation with their Claim Form are not limited to the number of bottles they can claim.

Claim Form

CLICK HERE TO FILE A CLAIM »

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

4/13/2020

Case Name

Rony Elkies, et al. v. Johnson & Johnson Services Inc., et al., Case No. 2:17-cv-07320, in the U.S. District Court for the Central District of California

Final Hearing

6/22/2020   UPDATED

UPDATE: The Johnson & Johnson Infants’ Tylenol Class Action Settlement was granted final approval on June 22, 2020. Let Top Class Actions know when you receive a check in the comments section below or on our Facebook page

Settlement Website

InfantsTylenolSettlement.com

Claims Administrator

Infant’s Tylenol Settlement Administrator
c/o KCC Class Action Services LLC
P.O. Box 43511
Providence, RI 02940-3511
1-866-458-2108

Class Counsel

Noel J. Nudelman
Tracy Reichman Kalik
HEIDEMAN NUDELMAN & KALIK PC

Defense Counsel

Matthew D. Powers
Joseph R. O’Connor
O’MELVENY & MYERS LLP

Read More Lawsuit & Settlement News:

Babyganics False Advertising Settlement Checks Mailed

How Do I File an Appeal for Unum Disability?

Owlet Class Action Says Smart Sock Doesn’t Work, Burns Infants’ Feet

Why Are They Recalling Valsartan?